Minerva Neurosciences, Inc. (NERV) Free cash flow 2018–2023
Minerva Neurosciences, Inc. (NERV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$14.8MFY2023 · since FY2018: -$42.0M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$14.8M | — |
| FY2018 | -$42.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NERV financial trends
NERV RevenueNERV Net incomeNERV Net marginNERV Gross profitNERV Gross marginNERV Operating incomeNERV Operating marginNERV Operating cash flowNERV Capital expendituresNERV Return on equityNERV Stock buybacksNERV Dividends paidNERV Total assetsNERV Total liabilitiesNERV Shareholders’ equityNERV overview →